REFRACTORY CLASSIC HODGKIN LYMPHOMA

Clinical trials for REFRACTORY CLASSIC HODGKIN LYMPHOMA explained in plain language.

Never miss a new study

Get alerted when new REFRACTORY CLASSIC HODGKIN LYMPHOMA trials appear

Sign up with your email to follow new studies for REFRACTORY CLASSIC HODGKIN LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 2 Completed 1 Terminated 1

New immune cell therapy targets Tough-to-Treat lymphomas

Disease control Completed

This study tested a new two-part immunotherapy for patients whose Hodgkin or Non-Hodgkin lymphoma has returned or not responded to other treatments. It combined a special antibody (AFM13) with donated immune cells (NK cells) to help the patient's own immune system find and kill c…

Matched conditions: REFRACTORY CLASSIC HODGKIN LYMPHOMA

Phase: PHASE1, PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control

Last updated Mar 20, 2026 14:47 UTC

REFRACTORY CLASSIC HODGKIN LYMPHOMA

Get alerted when new REFRACTORY CLASSIC HODGKIN LYMPHOMA trials appear

New immune cell therapy targets Tough-to-Treat lymphomas